Hyundai Pharm (004310) — Long-term Investment Intensity
Hyundai Pharm (004310) has a Long-term Investment Intensity of 4.1% as of November 2013. Long-term investments of ₩5.83 Billion represent 4.1% of total assets of ₩143.40 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check total reinvestment intensity of Hyundai Pharm to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hyundai Pharm Long-term Investment Intensity (2010–2013)
This chart shows how Hyundai Pharm's Long-term Investment Intensity has evolved across 4 annual periods from 2010 to 2013. As of November 2013, the intensity stands at 4.1%, reflecting long-term investments of ₩5.83 Billion against total assets of ₩143.40 Billion KRW. Explore Hyundai Pharm cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Hyundai Pharm (2010–2013)
The table below presents the year-by-year Long-term Investment Intensity for Hyundai Pharm from 2010 to 2013, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Hyundai Pharm worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2013 | 4.1% | ₩5.83 Billion | ₩143.40 Billion | ▲ +0.4 pp |
| 2012 | 3.7% | ₩5.47 Billion | ₩149.90 Billion | ▲ +1.2 pp |
| 2011 | 2.4% | ₩3.80 Billion | ₩156.95 Billion | ▼ -3.2 pp |
| 2010 | 5.6% | ₩7.32 Billion | ₩130.98 Billion | — |